Literature DB >> 21149040

The association of ocular dominance and the preferred eye for fixation in intermittent exotropia: a guide to choosing the eye for unilateral surgery.

B L Quah, Y Lu, D Smith.   

Abstract

OBJECTIVE: Recession of the lateral rectus muscle of the more frequently deviating eye in patients with small-angle intermittent exotropia has yielded good results. However, sometimes neither history nor clinical examination can identify this eye. This study sought to determine if the dominant eye of patients with intermittent exotropia is the preferred eye for fixation i.e., not the more frequently deviating eye.
METHODS: We recruited 40 patients (33 males, 7 females) aged 2.5 to 44.0 years (mean 9.5, SD 8.7) who had intermittent exotropia and attended our eye clinic between September 1998 and April 1999. Exclusion criteria included age (patients too young to cooperate), previous strabismus surgery, poor vision, neurological disorders or abnormal ocular motility, and unsuccessful determination of the preferred eye for fixation from history and examination. The preferred eye for fixation was determined by an orthoptist using cover tests, the dominant eye by an ophthalmologist using sighting and convergence near-point tests.
RESULTS: Tests showed that the dominant eye was almost invariably the same eye as the preferred eye for fixation.
CONCLUSIONS: For patients who have small-angle intermittent exotropia, when the more frequently deviating eye cannot be definitely determined before unilateral surgery, the sighting test can help identify the dominant eye.

Entities:  

Year:  2001        PMID: 21149040     DOI: 10.3368/aoj.51.1.111

Source DB:  PubMed          Journal:  Am Orthopt J        ISSN: 0065-955X


  1 in total

1.  The influence of ocular sighting dominance on Fundus torsion in patients with unilateral congenital superior oblique palsy.

Authors:  Dae Hee Kim; Hyuna Kim; Hyun Taek Lim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-19       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.